Crinetics Pharmaceuticals Inc

CRNX NASDAQ Santé & Biotech États-Unis US22663K1079
33.98 $
0.06 %

Crinetics Pharmaceuticals est engagée dans le développement de traitements hormonaux pour les maladies endocriniennes rares et sévères.

Performance & Momentum

6 Months 29.06 %
1 Year 5.27 %
3 Years 56.81 %
5 Years 100.12 %

Similar stocks to Crinetics Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Crinetics Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases